Articles Archive - Healthed

Articles

Read the latest articles relevant to your clinical practice, including exclusive insights from Healthed surveys and polls.

By reading selected clinical articles, you earn CPD in the Educational Activities (EA) category whenever you click the “Claim CPD” button and follow the prompts.

Infectious diseases, Public health

Clinical Articles

We’re in a new COVID wave. What can we expect this time?

Australia is now into its next COVID wave. But it has taken several months for a consistent pattern to emerge across Australia.

By Prof James Wood, A/Prof Bette Liu, Prof Katie Louise Flanagan, A/Prof Stuart Turville

Dermatology, Drugs and devices, Pharmacology

Clinical Articles

Product Explainer – Calcipotriol and betamethasone dipropionate foam spray for the topical treatment of psoriasis vulgaris in adults

Healthed Product Explainers feature leading experts describing their own views on products, devices and related developments and why they are relevant to general practice.

By Healthed

Accreditation

Clinical Articles

RACGP approval rating still positive, but trending downward

After clawing its way up from rock bottom approval ratings in 2018, the College is still getting positive marks, but they’re steadily slipping.

By Healthed

Diet and nutrition

Clinical Articles

Obesity drugs: Who will lose weight and for how long?

Which factors predict better outcomes with GLP-1 RAs and their successors...

By Manuela Callari

Pain medicine

Clinical Articles

Understanding that chronic back pain originates from within the brain could lead to quicker recovery, a new study finds

Most people with chronic back pain naturally think their pain is caused by injuries or other problems in the body such as arthritis or bulging disks...

By Yoni Ashar

Pain medicine

Clinical Articles

Mastering migraine management in a changing treatment landscape

What you need to know about CGRP targeted therapies, from changes in PBS criteria to precautions in different populations...

By Lakshini Mendis-David

Evidence-based medicine, Oncology

Clinical Articles

An experimental treatment against ‘certain death’

It is risky and untested treatment. It could shorten his life or make it a whole lot worse. But it’s a risk Professor Richard Scolyer is willing to take, desperate to try and save his own life...

By Healthed

Neurology

Clinical Articles

Cognitive testing for dementia

Whether it’s part of an over 75 health assessment or fitness to drive assessment, investigating patients’ concerns about impairment, or tracking progress over time, cognitive screening is important.

By Dr Sarah Tedjasukmana

Neurology

Clinical Articles

Your biological age predicts dementia and stroke regardless of your actual age – new study

As we journey through life, the risk of developing chronic diseases, including cancer, heart disease and neurological disorders, increases significantly.

By Jonathan Ka Long Mak, A/Prof Sara Hägg

Public health

Clinical Articles

Three problems with the bulk billing incentive

The tripled bulk billing incentive came into effect on Wednesday, but will it result in real change? A survey of frontline GPs has identified three problems with the policy...

By Lynnette Hoffman

Diabetes and metabolism, Diet and nutrition

Clinical Articles

Obesity drugs – What’s around the corner

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

By Manuela Callari

Accreditation

Clinical Articles

Side hustle: How this GP turned her love of writing into a complementary career

Exhausted by full time GP work, Linda’s carved out a dual career as a medical writer.

By Ben Falkenmire

Articles

We’re in a new COVID wave. What can we expect this time?

Australia is now into its next COVID wave. But it has taken several months for a consistent pattern to emerge across Australia.

Product Explainer – Calcipotriol and betamethasone dipropionate foam spray for the topical treatment of psoriasis vulgaris in adults

Healthed Product Explainers feature leading experts describing their own views on products, devices and related developments and why they are relevant to general practice.

RACGP approval rating still positive, but trending downward

After clawing its way up from rock bottom approval ratings in 2018, the College is still getting positive marks, but they’re steadily slipping.

Obesity drugs: Who will lose weight and for how long?

Which factors predict better outcomes with GLP-1 RAs and their successors...

Understanding that chronic back pain originates from within the brain could lead to quicker recovery, a new study finds

Most people with chronic back pain naturally think their pain is caused by injuries or other problems in the body such as arthritis or bulging disks...

Mastering migraine management in a changing treatment landscape

What you need to know about CGRP targeted therapies, from changes in PBS criteria to precautions in different populations...

An experimental treatment against ‘certain death’

It is risky and untested treatment. It could shorten his life or make it a whole lot worse. But it’s a risk Professor Richard Scolyer is willing to take, desperate to try and save his own life...

Cognitive testing for dementia

Whether it’s part of an over 75 health assessment or fitness to drive assessment, investigating patients’ concerns about impairment, or tracking progress over time, cognitive screening is important.

Your biological age predicts dementia and stroke regardless of your actual age – new study

As we journey through life, the risk of developing chronic diseases, including cancer, heart disease and neurological disorders, increases significantly.

Three problems with the bulk billing incentive

The tripled bulk billing incentive came into effect on Wednesday, but will it result in real change? A survey of frontline GPs has identified three problems with the policy...

Obesity drugs – What’s around the corner

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Side hustle: How this GP turned her love of writing into a complementary career

Exhausted by full time GP work, Linda’s carved out a dual career as a medical writer.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Articles

Australia is now into its next COVID wave. But it has taken several months for a consistent pattern to emerge across Australia.

Healthed Product Explainers feature leading experts describing their own views on products, devices and related developments and why they are relevant to general practice.

After clawing its way up from rock bottom approval ratings in 2018, the College is still getting positive marks, but they’re steadily slipping.

Which factors predict better outcomes with GLP-1 RAs and their successors...

Most people with chronic back pain naturally think their pain is caused by injuries or other problems in the body such as arthritis or bulging disks...

What you need to know about CGRP targeted therapies, from changes in PBS criteria to precautions in different populations...

It is risky and untested treatment. It could shorten his life or make it a whole lot worse. But it’s a risk Professor Richard Scolyer is willing to take, desperate to try and save his own life...

Whether it’s part of an over 75 health assessment or fitness to drive assessment, investigating patients’ concerns about impairment, or tracking progress over time, cognitive screening is important.

As we journey through life, the risk of developing chronic diseases, including cancer, heart disease and neurological disorders, increases significantly.

The tripled bulk billing incentive came into effect on Wednesday, but will it result in real change? A survey of frontline GPs has identified three problems with the policy...

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Exhausted by full time GP work, Linda’s carved out a dual career as a medical writer.

Get the app

Site

Company

Connect

Legal

LOG IN FOR FULL ACCESS

SIGN UP FOR A FREE HEALTHED ACCOUNT

Extra Details

PASSWORD RESET

Discover

Healthed